---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-007317"
form_type: "8-K"
ticker: "ENTA"
cik: "0001177648"
company_name: "ENANTA PHARMACEUTICALS INC"
filed_at: "2023-03-10T23:59:59+00:00"
generated_at: "2026-06-18T05:15:20.011336+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Enanta reports <5% cash held at SVB; no material impact on runway

## Summary
- Less than ~5% of Enanta's cash and marketable securities were in Silicon Valley Bank operating accounts.
- Remaining investments held in custody accounts at an independent institution.
- No material impact on projected cash runway or operations from SVB exposure.
- Disclosure made on March 10, 2023 amid SVB liquidity crisis.

## SEC filing metadata
- accession: 0000950170-23-007317
- form_type: 8-K
- ticker: ENTA
- cik: 0001177648
- company_name: ENANTA PHARMACEUTICALS INC
- filed_at: 2023-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1177648/000095017023007317/0000950170-23-007317-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1177648/000095017023007317/enta-20230310.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-007317
- JSON: https://secwatch.observer/filing/0000950170-23-007317.json
- Plain text: https://secwatch.observer/filing/0000950170-23-007317.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.